“Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-Line Clinical Trials”. Journal of Kidney Cancer, vol. 11, no. 3, Aug. 2024, pp. 51-58, https://doi.org/10.15586/jkcvhl.v11i3.352.